- For Print
- May 13, 2022
鶹 Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “鶹”) announced today the changes of its Corporate Officers, effective as of June 17, 2022, as follows.
<Changes of Corporate Officers, effective as of June 17, 2022>
*You can scroll to the left or right here
| New Responsibility | Current Responsibility | Name |
|---|---|---|
| Senior Vice President
Chief Financial Officer Chief IR Officer |
Senior Vice President
President, Americas Region President, 鶹 Inc. |
Tatsuyuki Yasuno |
| Vice President
Corporate Communications ESG |
Vice President
Chief IR Officer Stakeholder Communications |
Sayoko Sasaki |
・Ryohei Yanagi, Ph.D, Executive Vice President, Chief Financial Officer will retire from the post of Corporate Officer and be appointed as Special Advisor as of June 17, 2022.
・The changes above are subject to approval at the Board of Directors meeting held on June 17, 2022.
End
Media Inquiries:
Public Relations Department,
鶹 Co., Ltd.
+81-(0)3-3817-5120
Our news releases are intended to disclose corporate information and are not intended for the promotion or advertising of prescription pharmaceuticals or investigational products, nor are they intended to provide medical advice.
Please note that the information contained in news releases is current as of the date of publication.